期刊文献+

基于互联网的实时药品监管模式 被引量:2

Internet-based mode of real-time drug supervision and administration
下载PDF
导出
摘要 采取文献检索、比较研究、状况研究、发展性研究和个案分析的方法,探讨我国药品监管改革的有效方法。建立药品电子监管系统,建立各种既独立又相互联系实时更新的动态数据库,保证信息公开、透明,杜绝虚假药品信息的传递,保障广大公众的切身利益,维护药品行业的良好秩序。 By applying methods of literature review,comparative study,the research of situation,developmental study and case study,we discussed the mode of drug supervision and administration system.A drug electronic monitoring system is the independent but interrelated real-time dynamic updating of the databases.This system will guarantee the drug information being open and transparent,eliminating false drug information transmission,protecting the vital interests of the public,and vindicating the good order of domestic pharmaceutical industry.
出处 《中国新药杂志》 CAS CSCD 北大核心 2008年第22期1908-1909,1914,共3页 Chinese Journal of New Drugs
基金 大连市社科联项目(06DLSK144) 辽宁省社科规划基金项目(L07DJY069) 辽宁省社科联项目(2006lnsklktjjx-254-73)
关键词 实时药品监管模式 互联网 不正当行为 real-time drug supervision and administration mode internet improper behavior
  • 相关文献

参考文献7

  • 1ROBEZNIEKS A. FDA reform: is it enough? After a critical IOM report, agency moves to work harder on drug safety, but Congress presses ahead with its own changes [ J ]. Mod Healthc, 2007,37 (6):6-7, 1.
  • 2BERGER E. The future of drug safety: what the IOM report may mean to the emergency department[ J]. Ann Emerg Med,2007,49 (2) :193 - 195.
  • 3张新平,郑明节.论我国药品监管体制的特点与创新[J].中国药房,2006,17(13):966-968. 被引量:6
  • 4PSATY BM, BURKE SP. Protecting the health of the public-Institute of Medicine recommendations on drug safety [ J]. N Engl J Med, 2006,355(17) :1753 - 1755.
  • 5高翔,陈荣秋.对中国医药市场监管体系建设的构想[J].中国新药杂志,2007,16(19):1547-1552. 被引量:5
  • 6YOUNG D. IOM : congress must reform FDA to improve drug safety [J]. Am J Health Syst Pharm, 2006,63(21 ) :2032 -2034.
  • 7吴云红,朱亮,初炜,孔祥金.构建动态数据库改革医药监管模式[J].中华医学杂志,2008,88(9):580-582. 被引量:8

二级参考文献21

共引文献16

同被引文献24

  • 1胡颖廉.沿海十省(市)药品监管机构能力之比较研究[J].公共管理学报,2007,4(1):97-103. 被引量:17
  • 2曹燕,熊维政.我国药品广告市场现状及思考[J].中国药房,2007,18(7):495-497. 被引量:14
  • 3Gellad ZF, Lyles KW. Direct - to - consumer advertising of pharmaceuticals? [J] . Am J Med, 2007 , 120 (6) : 475 -480. [PMID: 17524744] IF 4. 907.
  • 4Holmer AF. Direct - to - consumer advertising strengthening our health care system? [J] . N Engl J Med, 2002, 346 (7) : 526 -528. [PMID: 11844858] IF52.589.
  • 5Hollon MF. Direct - to - consumer advertising: a haphazard approach to health promotion? [ J ] . JAMA, 2005, 293 (16) : 2030 - 2033. [ PMID: 15855439 ] IF25. 547.
  • 6Glinert LH, Schommer JC. Television advertisement format and the provision of risk information about prescription drug products? [ J ] . Res Social Adm Pharm, 2005, 1 (2): 185-210. [PMID: 17138474].
  • 7Donohue J. A history of drug advertising: the evol- ving roles of consumers and consumer protection [ J] . Milbank Q?, 2006, 84 (4) : 659 -699. [PMID: 17096638] IF3.5.
  • 8Evans GW, Friede AI. Liability for adverse events in direct - to - consumer advertising [ J ] . JAMA, 2003, 289 (20) : 2646 -2647. [PMID: 12771108] IF25. 547.
  • 9吴蓬,杨世民.药事管理学[M].人民卫生出版社.2007:237.
  • 10Bloom G, Standing H, Lloyd R. Markets, information asymmetry and health care: towards new social con tracts? [J] . Soc Sci Med, 2008, 66 (10) : 2076-2087.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部